329 Oyster Point Boulevard, 3rd Floor
South San Francisco
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and development of novel, targeted treatments. BlackThorn is building a robust pipeline of first- and best-in-class treatments, and is redefining the industry approach to drug discovery and development through its INFORM™ platform, which links brain physiology and its relationship to behavior. With its network of collaborations with leading academic investigators, BlackThorn is developing and deploying a set of technologies that will enable focused, rapid, resource-efficient translational studies for drug development. The company is headquartered in South San Francisco, California.
Executive Chairman: Mark Corrigan, M.D.
CSO: Bill Martin, Ph.D.
CMO: Annette Madrid, M.D.
Vice President, Operations and Corporate Development: Scott Forrest, Ph.D.
Please click here for BlackThorn's job opportunities.
Please click here for BlackThorn's pipeline.